SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Christophe Heinrich, Francesca M. Spagnoli, Benedikt Berninger, In vivo reprogramming for tissue repair, Nature Cell Biology, 2015, 17, 3, 204

    CrossRef

  2. 2
    Lorraine V Kalia, Anthony E Lang, Parkinson's disease, The Lancet, 2015,

    CrossRef

  3. 3
    Jaffar A. Al-Tawfiq, Ramzi W. Banda, Jihad Ghandour, Sterile cyst formation after intrathecal stem cell transplant for Parkinson's disease: A case presentation and literature review, Journal of Infection and Public Health, 2015,

    CrossRef

  4. 4
    Laura Stappert, Beate Roese-Koerner, Oliver Brüstle, The role of microRNAs in human neural stem cells, neuronal differentiation and subtype specification, Cell and Tissue Research, 2015, 359, 1, 47

    CrossRef

  5. 5
    Jan Pruszak, A brief perspective on neural cell therapy, Molecular and Cellular Therapies, 2014, 2, 1, 2

    CrossRef

  6. 6
    Christian Ineichen, Walter Glannon, Yasin Temel, Christian R. Baumann, Oguzkan Sürücü, A critical reflection on the technological development of deep brain stimulation (DBS), Frontiers in Human Neuroscience, 2014, 8,

    CrossRef

  7. 7
    Elena M. Vazey, Gary Aston-Jones, Designer receptors: therapeutic adjuncts to cell replacement therapy in Parkinson’s disease, Journal of Clinical Investigation, 2014, 124, 7, 2858

    CrossRef

  8. 8
    Silke Nuber, Daniel Tadros, Jerel Fields, Cassia Rose Overk, Benjamin Ettle, Kori Kosberg, Michael Mante, Edward Rockenstein, Margarita Trejo, Eliezer Masliah, Environmental neurotoxic challenge of conditional alpha-synuclein transgenic mice predicts a dopaminergic olfactory-striatal interplay in early PD, Acta Neuropathologica, 2014, 127, 4, 477

    CrossRef

  9. 9
    N. Daviaud, E. Garbayo, N. Lautram, F. Franconi, L. Lemaire, M. Perez-Pinzon, C.N. Montero-Menei, Modeling nigrostriatal degeneration in organotypic cultures, a new ex vivo model of Parkinson’s disease, Neuroscience, 2014, 256, 10

    CrossRef

  10. 10
    Debasmita Tripathy, Poonam Verma, Dominic N. Nthenge-Ngumbau, Meghna Banerjee, Kochupurackal P. Mohanakumar, Regenerative Therapy in Experimental Parkinsonism: Mixed Population of Differentiated Mouse Embryonic Stem Cells, Rather Than Magnetically Sorted and Enriched Dopaminergic Cells Provide Neuroprotection, CNS Neuroscience & Therapeutics, 2014, 20, 8
  11. 11
    Anne Rosser, Clive N. Svendsen, Stem cells for cell replacement therapy: A therapeutic strategy for HD?, Movement Disorders, 2014, 29, 11
  12. 12
    Sergey V Anisimov, Gesine Paul, Transplantation of mesenchymal stem cells: a future therapy for Parkinson’s disease?, Future Neurology, 2014, 9, 4, 475

    CrossRef

  13. 13
    Y. Lei, D. V. Schaffer, A fully defined and scalable 3D culture system for human pluripotent stem cell expansion and differentiation, Proceedings of the National Academy of Sciences, 2013, 110, 52, E5039

    CrossRef

  14. 14
    Ryan T. Funk, Arshak R. Alexanian, Enhanced dopamine release by mesenchymal stem cells reprogrammed neuronally by the modulators of SMAD signaling, chromatin modifying enzymes, and cyclic adenosine monophosphate levels, Translational Research, 2013, 162, 5, 317

    CrossRef

  15. 15
    Nicolas Daviaud, Elisa Garbayo, Paul C. Schiller, Miguel Perez-Pinzon, Claudia N. Montero-Menei, Organotypic cultures as tools for optimizing central nervous system cell therapies, Experimental Neurology, 2013, 248, 429

    CrossRef

  16. 16
    Andrea J. Mothe, Charles H. Tator, Review of transplantation of neural stem/progenitor cells for spinal cord injury, International Journal of Developmental Neuroscience, 2013, 31, 7, 701

    CrossRef